Laursen Van Swieten

PropTexx is a prominent global real estate technology company that focuses on enhancing the real estate sector through advanced artificial intelligence, machine learning, and deep learning solutions. The company develops a property technology platform that provides a comprehensive system for real estate professionals, facilitating the creation of online property listings. Its software incorporates high-tech functionalities, including the ability to generate engaging descriptions, pre-populate listings, virtual staging, and image tagging. By leveraging proprietary algorithms and a dedicated team of professionals, PropTexx aims to improve the quality and representation of property listings, enabling users to scale their operations effectively.

PropTexx is a prominent global real estate technology company that focuses on enhancing the real estate sector through advanced artificial intelligence, machine learning, and deep learning solutions. The company develops a property technology platform that provides a comprehensive system for real estate professionals, facilitating the creation of online property listings. Its software incorporates high-tech functionalities, including the ability to generate engaging descriptions, pre-populate listings, virtual staging, and image tagging. By leveraging proprietary algorithms and a dedicated team of professionals, PropTexx aims to improve the quality and representation of property listings, enabling users to scale their operations effectively.

Silenseed Ltd. is a biopharmaceutical company based in Jerusalem, Israel, that specializes in the discovery and development of RNA interference (RNAi)-based cancer therapies and delivery systems aimed at treating malignant solid tumors. The company employs its proprietary LODER delivery platform to enhance the effectiveness of its drug candidates. Its lead product, SiG12D-LODER, has successfully completed pre-clinical studies and an open-label Phase I clinical trial for pancreatic cancer. Additionally, Silenseed is developing Prostate-LODER, currently in pre-clinical studies for prostate cancer, and GBM-LODER, which targets Glioblastoma Multiforme, a type of malignant brain tumor. Founded in 2008, Silenseed is dedicated to innovating cancer treatment through its advanced drug delivery techniques.

Soltaro specializes in the development of solar battery storage solutions aimed at reducing energy consumption. The company offers lithium-ion phosphate batteries that can be integrated as hybrid systems or retrofitted to existing solar installations. These products enable customers to store solar energy generated from their photovoltaic systems, allowing for greater energy efficiency and cost savings on energy bills. By facilitating the storage of unused electricity, Soltaro's solutions contribute to more sustainable energy usage.